Pharmacy regulation and licensing
Federal and state requirements must become clear licensing steps, policies, training, monitoring, and inspection-ready records.
Capabilities
Areas of capability
Pharmacy operations, legal research, contracting, reimbursement, quality systems, investigations, evidence review, and enterprise leadership.
These subject areas are relevant to executive, attorney-advisor, healthcare investigation, regulatory, compliance, and strategic roles. Nothing on this website constitutes legal advice or a solicitation to provide legal services.
How the issues connect
Contracts, reimbursement, evidence, and compliance affect the same decisions.
PBM terms affect cash flow. Documentation affects audits. Accreditation affects market access. Regulatory duties shape commercial decisions. Leaders must assess those effects together before they grow into a larger operating failure.
503A compounding and quality systems
A sound 503A program connects SOPs, quality systems, staff training, hazardous-drug controls, documentation, and accreditation readiness.
Section 503B, FDA, DEA, and controlled substances
Inspection preparation, controlled-substance oversight, outsourcing-facility relationships, and current FDA requirements demand one coordinated record.
PBM contracting, reimbursement, and audits
PBM agreements, provider manuals, network access, claims, reimbursement, audits, and disputed records must be tested against daily workflow and patient access.
Investigations, litigation support, and evidence
Factual chronologies, claims data, purchasing records, document review, and governing law must support regulatory responses, investigations, and litigation decisions.
Commercial agreements, supply chains, and leadership
Pharmacy-services, wholesaler, supplier, procurement, rebate, vendor, confidentiality, and restrictive-covenant terms must be assessed in their operating context.
Research topics
Research topics
Professional opportunities